Filter Results
:
(95)
Show Results For
-
All HBS Web
(95)
- News (41)
- Research (26)
- Multimedia (3)
- Faculty Publications (9)
Show Results For
-
All HBS Web
(95)
- News (41)
- Research (26)
- Multimedia (3)
- Faculty Publications (9)
Page 1 of
95
Results
→
- 01 Sep 2007
- News
Stem Cell Man
Last year, Brock Reeve (MBA ’88) was named executive director of the Harvard Stem Cell Institute to bring his managerial and diplomatic skills to bear on achieving organizational cohesion and help speed...
View Details
- Research Summary
The Business of Stem Cells
By: Debora L. Spar
In 2004, the topic of stem cell research made both medical and moral headlines. Buoyed by a series of technological breakthroughs, stem cell scientists grew increasingly convinced that they would eventually be able to use embryonic stem cells -- the pluripotent cells...
View Details
- January 2009 (Revised February 2009)
- Case
Sydney IVF: Stem Cell Research
By: Robert L. Simons, Kathryn Rosenberg and Natalie Kindred
This case examines the strategy implementation and risk management decisions at Sydney IVF, a research-based in vitro fertilization and stem cell company based in Australia. Drs. Robert Jansen and Jock Anderson, who co-founded Sydney IVF in 1986, developed novel...
View Details
Keywords:
Ethics;
Governing Rules, Regulations, and Reforms;
Innovation and Management;
Growth and Development Strategy;
Risk Management;
Genetics;
Commercialization;
Health Industry;
Australia
Simons, Robert L., Kathryn Rosenberg, and Natalie Kindred. "Sydney IVF: Stem Cell Research." Harvard Business School Case 109-017, January 2009. (Revised February 2009.)
- November 2006 (Revised March 2008)
- Case
The Harvard Stem Cell Institute
Describes a set of issues confronting the leaders of the Harvard Stem Cell Institute, an innovative cross-university effort to accelerate scientific discovery and translation in the domain of stem cells. Covers a wide range of topics, including understanding how...
View Details
Keywords:
Talent and Talent Management;
Higher Education;
Entrepreneurship;
Collaborative Innovation and Invention;
Intellectual Property;
Research and Development;
Genetics;
Biotechnology Industry;
Health Industry;
Massachusetts
Sahlman, William A. "The Harvard Stem Cell Institute." Harvard Business School Case 807-096, November 2006. (Revised March 2008.)
- 01 Dec 2004
- News
The Future of Stem Cells
Stem cells have been much in the news recently. But the hot-button ethical and political questions currently surrounding this area of research may ultimately prove moot, if the past is any guide. Business...
View Details
Keywords:
Garry Emmons
- June 2010 (Revised May 2017)
- Teaching Note
Sydney IVF: Stem Cell Research
By: Robert Simons and Kathryn Rosenberg
Teaching Note for 109017.
View Details
Keywords:
Strategy And Execution;
Management Control Systems;
Levers Of Control;
Strategy;
Risk Management;
Decisions;
Cooperative Ownership;
Product Development;
Moral Sensibility;
Governing Rules, Regulations, and Reforms;
Expansion;
Science-Based Business;
Research;
Management Practices and Processes;
Business Subsidiaries;
Biotechnology Industry;
Sydney
- 01 Jun 2008
- News
“Where can we find such a person?”
In a 2006 case he prepared about the Harvard Stem Cell Institute (HSCI), HBS professor Bill Sahlman quotes HSCI cochairman and codirector of science Douglas Melton as Melton pondered the management skills...
View Details
- 2007
- Article
Selling Stem Cell Science: How Markets Drive Law along the Technological Frontier
By: Debora Spar and Anna Harrington
Spar, Debora, and Anna Harrington. "Selling Stem Cell Science: How Markets Drive Law along the Technological Frontier." American Journal of Law & Medicine 33, no. 4 (2007): 541–565.
- 17 Aug 2011
- News
Breath of Life
Swedish procedure was a “bioreactor, a shoe box–size device similar to a spinning rotisserie machine. The artificial scaffold was placed on the bioreactor, and stem cells extracted from the patient’s bone...
View Details
- 01 Dec 2010
- News
Chaotic Funding Derails Research
investigators, even the most successful ones in the world, spend at least 25 percent of their time trying to get money. If they can’t get money, they lay off people and cancel projects. Now imagine you are a postdoc in a lab and are working on a project to use human...
View Details
- 20 Jun 2019
- Blog Post
What is the MS/MBA Biotechnology: Life Sciences Program? A Q&A with Bill Anderson, Senior Lecturer on Stem Cell and Regenerative Biology
Students should also love to tackle big questions, analyze data critically, and devise creative solutions. Most students will have an undergraduate degree in the life sciences or another STEM field, or extensive biotech experience. Is...
View Details
- 06 Jun 2018
- Video
Tarran Pierfelice, Blavatnik Fellow 2018-2019
- January 2009 (Revised July 2010)
- Case
iZumi
By: Robert F. Higgins, Jacob Ian Broder-Fingert, Eliot Sherman and Sidhartha Palani
Presents the issues faced while building an innovative company in an emerging space with new intellectual property from the perspective of a venture capitalist. Beth Seidenberg, a partner at the venture capital firm Kleiner Perkins Caufield & Byers (KPCB), had helped...
View Details
- 12 Apr 2022
- Blog Post
The Many Languages of Medicine to Impact Care Delivery
decision. On the other hand, at the Harvard Stem Cell and Regenerative Biology department, we interrogate scientific papers and consider the business case for the commercialization of cutting-edge science....
View Details
- 02 Dec 2010
- News
Harvard Business School Names New Kaplan Life Sciences Fellows
- 18 Jun 2019
- Video
A joint degree that blends business, science, and ethics
- 15 Sep 2020
- Blog Post
One Month into the New MS/MBA Biotech
Harvard’s new MS/MBA Biotechnology: Life Sciences joint degree program confers an MBA from Harvard Business School and a Master of Science from the Graduate School of Arts and Sciences and Harvard Medical School in the Harvard Department of View Details
- 20 Jun 2019
- News